
Artenip-L Tablet
Marketer
Nova Indus Pharmaceuticals
Salt Composition
Artemether (80mg) + Lumefantrine (480mg)
Overview Artenip-L Tablet
Malarone-L tablets effectively combat malaria in patients of all ages. This dual-action medication, comprised of two antimalarial drugs, targets the parasites responsible for the disease, halting its progression. Importantly, it's designed for treating existing infections, not for preventative measures or severe malaria complications impacting vital organs (brain, lungs, kidneys). Optimal absorption requires ingestion with food. Always adhere to your physician's prescribed dosage and duration; exceeding the recommended amount can be detrimental. Complete the entire course to ensure complete eradication of the infection. Common side effects include headaches, appetite loss, fatigue, arthralgia, and myalgia; dizziness may also occur. Report any persistent or worsening symptoms to your doctor. Prior to commencing treatment, disclose all current medications to your doctor, especially if you are pregnant or breastfeeding, as the drug may pose risks to the fetus or infant.
Uses of Artenip-L Tablet
Managing Malaria Infection
Major Benefits of Artenip-L Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Artenip-L Tablets should be administered with food.
Common Side effects of Artenip-L Tablet:
- Headache
- Loss of appetite
- Dizziness
- Weakness
- Joint pain
- Muscle pain
How to use Artenip-L Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Artenip-L Tablets should be taken with a meal.
How Artenip-L Tablet works:
Artemether and Lumefantrine, the active components of Artenip-L Tablet, combat malaria through a synergistic antiparasitic action. Their mechanism involves elevating blood haem levels, a compound harmful to the malaria parasite. This elevated toxicity eradicates the parasite, thus halting the infection's progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Artenip-L Tablet may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Artenip-L Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Patient consultation with their doctor is recommended.
Breast feedingSAFE IF PRESCRIBED
Lactation and Artenip-L Tablet use appear compatible. Available human data indicate minimal infant risk associated with the medication.
DrivingUNSAFE
Driving may be impaired by Artenip-L Tablet, which can cause drowsiness, dizziness, and visual disturbances. Avoid operating vehicles if you experience these effects.
KidneyCAUTION
Caution is advised when prescribing Artenip-L tablets to individuals with severe renal impairment; dosage modification may be necessary. Physician consultation is recommended. Dosage alteration is not typically required for patients exhibiting severe kidney disease.
LiverCAUTION
Caution is advised when prescribing Artenip-L Tablets to individuals with significant hepatic impairment. Dosage modification of Artenip-L Tablets might be necessary; physician consultation is recommended. However, altering the dose is not generally advised for patients with severe liver dysfunction.
What if you forget to take Artenip-L Tablet :
Should you forget a dose of Artenip-L Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Artenip-L Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimalarial Drugs |
